Publication:

Recent progress in allosteric modulators for GluN2A subunit and development of GluN2A-selective nuclear imaging probes

Date

Date

Date
2019
Journal Article
Published version
cris.lastimport.scopus2025-06-01T03:39:05Z
cris.lastimport.wos2025-07-21T02:04:17Z
dc.contributor.institutionUniversity of Zurich
dc.date.accessioned2020-02-05T18:44:42Z
dc.date.available2020-02-05T18:44:42Z
dc.date.issued2019-06-30
dc.description.abstract

N-methyl-D-aspartate (NMDA) receptors play key roles in physiology by regulating the synaptic plasticity and the cellular mechanism involved in learning and memory. The GluN2A subunit is the most abundant expression of NMDA receptors in mature brain, and its dysfunction has been implicated in various neurological disorders. However, the function of GluN2A subunit in physiological and pathological conditions is not yet completely unveil due to the lack of subunit-selective ligands, including specific positron emission tomography (PET)/single photon emission computed tomography (SPECT) imaging probes. In this review, recent progresses in understanding its pathophysiological role, the structure-activity relationship, and the postulated mechanisms of novel GluN2A ligands as well as status of molecular imaging probes for PET are summarized.

dc.identifier.doi10.1002/jlcr.3744
dc.identifier.issn0362-4803
dc.identifier.scopus2-s2.0-85068937534
dc.identifier.urihttps://www.zora.uzh.ch/handle/20.500.14742/165108
dc.identifier.wos000475397300019
dc.language.isoeng
dc.subject.ddc610 Medicine & health
dc.title

Recent progress in allosteric modulators for GluN2A subunit and development of GluN2A-selective nuclear imaging probes

dc.typearticle
dcterms.accessRightsinfo:eu-repo/semantics/closedAccess
dcterms.bibliographicCitation.journaltitleJournal of Labelled Compounds and Radiopharmaceuticals
dcterms.bibliographicCitation.number8
dcterms.bibliographicCitation.originalpublishernameWiley-Blackwell Publishing, Inc.
dcterms.bibliographicCitation.pageend560
dcterms.bibliographicCitation.pagestart552
dcterms.bibliographicCitation.pmid31037756
dcterms.bibliographicCitation.volume62
dspace.entity.typePublicationen
uzh.contributor.affiliationETH Zürich
uzh.contributor.affiliationETH Zürich, UniversitatsSpital Zurich
uzh.contributor.affiliationETH Zürich
uzh.contributor.affiliationETH Zürich, Paul Scherrer Institut
uzh.contributor.authorHe, Yingfang
uzh.contributor.authorMu, Linjing
uzh.contributor.authorAmetamey, Simon M
uzh.contributor.authorSchibli, Roger
uzh.contributor.correspondenceNo
uzh.contributor.correspondenceNo
uzh.contributor.correspondenceNo
uzh.contributor.correspondenceYes
uzh.document.availabilityno_document
uzh.eprint.datestamp2020-02-05 18:44:42
uzh.eprint.lastmod2025-07-21 02:10:37
uzh.eprint.statusChange2020-02-05 18:44:42
uzh.harvester.ethNo
uzh.harvester.nbNo
uzh.jdb.eprintsId40292
uzh.oastatus.unpaywallclosed
uzh.oastatus.zoraClosed
uzh.publication.citationHe, Yingfang; Mu, Linjing; Ametamey, Simon M; Schibli, Roger (2019). Recent progress in allosteric modulators for GluN2A subunit and development of GluN2A-selective nuclear imaging probes. Journal of Labelled Compounds and Radiopharmaceuticals, 62(8):552-560.
uzh.publication.originalworkfurther
uzh.publication.publishedStatusfinal
uzh.scopus.impact8
uzh.scopus.subjectsAnalytical Chemistry
uzh.scopus.subjectsBiochemistry
uzh.scopus.subjectsRadiology, Nuclear Medicine and Imaging
uzh.scopus.subjectsDrug Discovery
uzh.scopus.subjectsSpectroscopy
uzh.scopus.subjectsOrganic Chemistry
uzh.workflow.doajuzh.workflow.doaj.false
uzh.workflow.eprintid180922
uzh.workflow.fulltextStatusnone
uzh.workflow.revisions40
uzh.workflow.rightsCheckkeininfo
uzh.workflow.sourcePubMed:PMID:31037756
uzh.workflow.statusarchive
uzh.wos.impact7
Publication available in collections: